|
本帖最后由 jaydad 于 2015-6-14 13:41 编辑
Ariad company's financial stress
声明一下, 我不推荐AP26113 治疗易/特 耐药 EGFR 病人
CAMIDGE 2013 ASCO
Among patients with a history of EGFRm that were evaluable for response,
1/18 patients experienced PR and 7/18 experienced SD (including 4 with
T790M)
• 3 evaluable patients were treated who had an EGFR TKI as their last therapy
prior to AP26113 and had T790M detected during/after treatment with that
therapy; all 3 started AP26113 more than 1 month after stopping the prior
EGFR TKI
– 2 of 3 had SD with AP26113; the third patient discontinued prior to receiving a follow-up scan
AP26113针对EGFR T790M突变可能有效.
================================
我de推荐
好象PF-02899804 简称 804 最有效, 其他的可以考虑
2992 阿法替尼
184 卡博替尼
4002
AP26113 对EGFR 肺癌疗效有效率较低, 除非你有证据是 T790M 抗性
|
|